← FDA Drug Approvals (Drugs@FDA)

AMANTADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS · Approved 2024-08-26

Drug application

FDA Application #
ANDA214897
Application type
Abbreviated New Drug Application (Generic)
Brand name
AMANTADINE
Generic name
Amantadine
Active ingredients
AMANTADINE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing status
None (Tentative Approval)
Sponsor
ZYDUS
First approval
2024-08-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown